SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to build elite biotechnology companies. SR One’s mission is to translate innovative technologies into potential next-generation medicines that benefit patients with significant unmet medical needs. SR One has offices in San Francisco, CA and London, UK. For more information, please visit www.srone.com.